drugset / Trial / NCT00503360

Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension

NCT00503360 ↗

Phase 1 Completed 80 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the tolerability and safety of SAD448 and explore the compound's effect on intraocular pressure in subjects with ocular hypertension.

Timeline

Start
2007-04
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject SAD448 Small molecule — —

Indications